Dr. Jennifer McVean, MD, is a nationally recognized pediatric endocrinologist and diabetes specialist dedicated to improving the lives of children and families affected by diabetes and endocrine disorders. Diagnosed with Type 1 diabetes at age 11, Dr. McVean brings a unique perspective to patient care by combining personal experience with extensive medical expertise.
Professional Background
Dr. McVean earned her medical degree from the University of Minnesota Medical School, completed her pediatric residency at the University of Colorado, and pursued a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held leadership, academic, and clinical positions with respected healthcare organizations, including the University of Minnesota, Children’s Minnesota, Gundersen Health System, Hudson Physicians, and Medtronic Diabetes.
Expertise and Contributions
Specializing in Type 1 Diabetes, pediatric diabetes management, insulin pump therapy, continuous glucose monitoring (CGM), growth disorders, thyroid disorders, and pediatric endocrinology, Dr. McVean has contributed significantly to advancements in automated insulin delivery systems and diabetes technology adoption. Her work has improved outcomes for pediatric patients worldwide.
As Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean has been instrumental in developing and promoting technologies that enhance diabetes management. Her research includes studies on the MiniMed™ 780G system, demonstrating its effectiveness in reducing the burden of diabetes management by improving sleep and glycemic control overnight. [1]
Leadership and Advocacy
Dr. McVean actively participates in numerous diabetes advocacy and educational organizations, including the Juvenile Diabetes Research Foundation (JDRF), American Diabetes Association (ADA), ADA Camp Needlepoint, TrialNet Research Network, and the Pediatric Endocrine Society. She has dedicated years to mentoring, research, education, and community outreach focused on improving diabetes awareness, prevention, and treatment.
Her personal mission is to help individuals with diabetes achieve healthier, more independent lives while advancing innovations that reduce the burden of disease for future generations.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
To learn more about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.